Eric A. Dietrich, PharmD, BCPS

An 85-year-old hypertensive woman with noted atrial fibrillation is starting antithrombotic therapy with warfarin. Here's a breakdown of the treatment protocol.

Patients with active cancer are at an increased risk for venous thromboembolism (VTE), which is a cause of significant morbidity and mortality.

Home monitoring of blood pressure and blood glucose have become mainstays in the treatment of hypertension and diabetes, allowing patients to take an active role in their disease management.

The advent of a variety of methodologically new antithrombotic agents has provided clinicians with important choices to make when selecting treatments for commonplace syndromes, such as atrial...

Allergies to sulfa-containing drugs are common and lead to significant concern regarding alternative medications as well as cross-reactivity.

Over the past couple of years 3 novel oral anticoagulants (NOACs) have been FDA approved: dabigatran (Pradaxa, Boehringer Ingelheim), rivaroxaban (Xarelto, Janssen), and apixaban. Originally approved for...